Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity - Maira, S M; Stauffer, F; Brueggen, J; Furet, P; Schnell, C; Fritsch, C; Brachmann, S; Chene, P; De Pover, A; Schoemaker, K; Fabbro, D; Gabriel, D; Simonen, M; Murphy, L; Finan, P; Sellers, W; Garcia-Echeverria, C (Mol Cancer Ther, 2008)